Genzyme, one of the world-leading biotechnology companies, is committed to significantly improving the lives of the patients suffering from serious medical conditions. Genzyme Laboratories designed Synvisc orthopedic products used for osteoarthritis pain relief.
Genzyme Corporation is one of the most well-known biotechnological companies in the US. It was founded in 1981 and is headquartered in Cambridge, Massachusetts. With 11,000 employees spread across 40 countries and 17 manufacturing facilities, it has grown to become the third-largest biotechnology company in the world. Genzyme, a subsidiary of Sanofi, is present in approximately 65 countries. Currently, the company is concerned with developing innovative medicines in six specialized fields: lysosomal storage disorders, renal disease, orthopaedics, transplant and immunological diseases, oncology, and genetics and diagnostics.
Genzyme manufactures Synvisc orthopaedic injectable products to help patients suffering from osteoarthritis. Synvisc is indicated to mitigate the stiffness and pain caused by osteoarthritis in the knee, hip, ankle, or shoulder. Synvisc supplements the joint fluid to reduce discomfort and enhance the joint’s natural shock absorption properties. With just one injection, it can relieve knee pain for up to six months.
Major Medical Solutions offers to buy Genzyme products for osteoarthritis treatment — Synvisc Classic and Synvisc One. We offer the best wholesale price for Genzyme knee injections and fast worldwide delivery.
Genzyme Pharmaceuticals is a leader in the endeavor to develop and employ the most advanced technologies in the life sciences. It provides cutting-edge products and services that help patients all across the world. Genzyme was honored with the National Medal of Technology in 2007, the highest award presented by the President of the United States for technological innovation.
